Skip to main navigation Skip to search Skip to main content

Percutaneous patent foramen ovale closure for hypoxaemia at the age of 73: a case report showing immediate benefit

  • CAHAL
  • Amsterdam UMC - University of Amsterdam

Research output: Contribution to journalArticleAcademicpeer-review

40 Downloads (Pure)

Abstract

Background Approximately 25% of the general population has a patent foramen ovale (PFO) that remains asymptomatic in the vast majority. Right-to-left shunt (RLS)-mediated hypoxaemia is a rare associated condition of PFO. Case summary This report describes a case of percutaneous PFO closure for hypoxaemia in a 73-year-old patient showing immediate clinical benefit. She experienced progressive dyspnoea on exertion requiring oxygen therapy. SaO2 was 87% at rest without oxygen therapy, which increased to 98% after percutaneous PFO closure. Discussion Most PFOs remain clinically insignificant but RLS-mediated hypoxaemia is a rare phenomenon that can occur even at advanced age. Percutaneous PFO closure is a safe and effective therapy option that provides immediate improvement of hypoxaemia.
Original languageEnglish
Article numberytae415
JournalEuropean Heart Journal - Case Reports
Volume8
Issue number8
DOIs
Publication statusPublished - 1 Aug 2024

Keywords

  • Case report
  • Hypoxaemia
  • Patent foramen ovale
  • Percutaneous closure
  • Right-to-left shunt

Fingerprint

Dive into the research topics of 'Percutaneous patent foramen ovale closure for hypoxaemia at the age of 73: a case report showing immediate benefit'. Together they form a unique fingerprint.

Cite this